Hero - patient with doctor

Sobi in PNH –
Our strength lies in rare diseases

Sobi in PNH –
Our strength lies in rare diseases

At Sobi, we’re developing innovative new medicines to raise standards of care for people with paroxysmal nocturnal haemoglobinuria (PNH).
PNH is a life-threatening rare blood disorder, characterised by haemolytic anaemia, thrombosis and debilitating symptoms.1

Introducing PNH

Dr Anders Ullman, Chief Medical Officer of Sobi, provides an introduction to PNH


Highlighting PNH unmet medical needs

Living with PNH

Diagnosing PNH can be a challenge

PNH – Unrelieved symptoms

Despite current treatments, people with PNH may still experience debilitating symptoms

PNH – When surviving isn’t enough

Transforming life for people with PNH

PNH – Mode of disease

Find out what causes PNH

  1. Hill A, DeZern AE, Kinoshita T & Brodsky RA. Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers 2017;3:17028.

PNH: Paroxysmal nocturnal haemoglobinuria

Job code: PP-17755 | Date of preparation: March 2023

Intended for healthcare professional only